Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spasmofen versus intravenous ketorolac for acute renal colic
ACTRN12614000246684Phase 4Completed
- Sponsor
- Green Clinic and Research Center
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Renal colic comparing Spasmofen group with Ketorolac group (2 arms). Primary endpoints: Treatment success at 60 minutes and Percent reduction in visual pain analog scale score. Started Mar 2007; status: completed.
02
Drugs
ketoprofen + hyoscine butylbromideketorolac
03
Conditions
Renal colic
Beyond the preview
Go deeper on ACTRN12614000246684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000246684.